Elliott Sells Out Of Celesio, Seals Takeover Deal

Jan 27 2014 | 12:38pm ET

Elliott Management will ensure the success of a pharmaceutical merger, after all.

The hedge fund, which ended its battle with McKesson Corp. when the company boosted its offer for Celesio by 2%, has agreed to sell its roughly 25% stake in Celesio to Franz Haniel & Cie, which already owns a majority stake in the company. In turn, Haniel has accepted McKesson's offer, which the latter had dropped two weeks ago after it failed to win the necessary 75% backing from shareholders.

In addition, Elliott has agreed to sell its convertible bonds in Celesio to McKesson at an undisclosed price, and to stop interfering with the transaction, Reuters reports. Elliott reportedly made most of its profit on the deal through the sale of the convertible bonds.

The deals will allow McKesson to take control of Celesio through a domination and profit-and-loss transfer agreement, one that will eventually force Celesio's minority shareholders to give up their stock.

"We are excited to move forward with our acquisition of Celesio," McKesson CEO John Hammergren said.


In Depth

AIMA: Smaller Firms Remain the Lifeblood of the Hedge Fund Industry

Jul 26 2017 | 5:55pm ET

It is a hedge fund industry truism that the largest managers receive the most attention...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Rastegar: PE Real Estate Gains Momentum as Uncertainty Rises

Jul 21 2017 | 6:04pm ET

The steady march of equity markets and fundamental shift in the direction of Fed...

 

From the current issue of